Planning and Evaluation Core

7.0概述 为了保持这一伙伴关系预期的高质量研究，严格的规划和评估过程 已实施以监控协作建设以及所有项目、计划和核心 伙伴关系的使命、宗旨和宗旨，以及U54的使命/宗旨和宗旨 机制本身。我们的目的是利用合作伙伴的资金进行项目和计划，以培养他们的 发展，但不提供长期支持。作为建立和保持卓越的一部分，所有项目 和计划经过我们内部和外部委员会的严格审查(表36)，并 预计(也必须制定计划)向美国国立卫生研究院或类似机构申请外部资金。 这些规划和评价进程也有助于准确评估伙伴关系的 实现近期(1-3年)和中期(4-5年)目标的有效性(见第1.5节) 建立可持续的研究基础设施(例如，关键人员招聘、临床应计核心、 组织核心，分配的建筑空间，并进一步定义开发的规划方法 获得癌症中心指定的路线图)。更不用说，在战略上，一个强大的 需要规划和评价进程，以协助伙伴关系实现其长期目标(U54后 资金)重新获得UPRCCC的NCI-称号。尽管重新获得NCI-称号并不是一个直接的 在U54机制范围内的目标，作为和平机构，我们认为我们当务之急不仅是 考虑U54的具体情况，但要追求U54以外的目标。对我们来说，重新获得NCI-称号 是朝着建立一个更强大的国家癌症计划迈出的积极一步，旨在了解 癌症健康差距背后的原因及其对我们服务人群的影响。

7.0 Overview To sustain the high quality of research expected from this Partnership, strict planning and evaluation processes have been implemented to monitor collaboration building, as well as all projects, programs and cores against both the Partnership's mission, goals and objectives, and the mission/goals and objectives of the U54 mechanism itself. It is our intent to utilize Partnership funding for projects and programs to nurture their development, but not to provide long-term support. As a part of building and sustaining excellence, all projects and programs undergo a strenuous review by our internal and external committees (Table 36) and are expected to (and must develop a plan to) apply for external funding from the NIH or an equivalent agency. These planning and evaluation processes are also instrumental in accurately assessing the Partnership's effectiveness towards achieving its immediate (1-3 years) and intermediate (4-5 years) goals (See Section 1.5) of establishing a sustainable research infrastructure (e.g., key personnel recruitment, clinical accrual cores, tissue cores, assigned building space, and further defining programmatic approaches toward the development of the roadmap to obtain cancer center designation) at the UPRCCC. Not to mention, strategically, a strong planning and evaluation process is needed to aid the Partnership in achieving its long-term goal (post-U54 funding) of regaining NCI-designation for the UPRCCC. Although regaining NCI-designation is not a direct goal within the scope of the U54 mechanism, as Pis, we believe that it is imperative for us to not just think in terms of U54 specifics, but to pursue goals beyond the U54. For us, regaining NCI-designation is a positive step towards building a stronger national cancer program aimed at understanding the reasons behind cancer health disparities and their impact on the populations we serve.